All peptides

DSIP

Also known as Delta Sleep-Inducing Peptide

An endogenous-like nonapeptide investigated for possible roles in sleep physiology, stress signaling, and neuroendocrine regulation.

Regulatory status
Investigational / research peptide

DSIP is not an approved treatment for insomnia or any other condition in the United States or elsewhere.

Half-life
Human pharmacokinetic half-life not well established.

Animal pharmacokinetic values are sometimes quoted online; they are not a substitute for human data and are not reproduced here as human half-life.

Route
Intravenous and subcutaneous in published experimental studies

Research use / investigational only. No validated clinical route of administration.

Evidence
Multiple randomized controlled trials in humans

Mechanism of action

The primary receptor and exact molecular mechanism of DSIP remain incompletely characterized. Research has examined possible modulation of sleep-wake physiology, neuroendocrine signaling, stress responses, circadian physiology, thermoregulation, and pain-related signaling, largely in animal and older human experimental work. No specific receptor target has been reliably established.

DSIPUncharacterized central targetsSleep-wake & neuroendocrine signaling

Studied and reported uses

  • Sleep physiology

    Historically studied for possible effects on sleep onset and sleep architecture. Human data are older, small, and mixed.

  • Stress physiology

    Experimental literature has examined potential effects on physiological stress responses, mostly in animal models.

  • Circadian regulation

    Some reported effects appear influenced by circadian state and timing of administration.

  • Neuroendocrine research

    Investigated for possible interactions between central nervous system signaling and endocrine output.

Dosing information

Clinical research informationNo established clinical dosing regimen exists for DSIP.
Study protocolsPublished experimental work used varied protocols depending on formulation, route, and study design (dose used in that study, not a recommended dose).

Ranges are reported from literature and clinical labeling for reference only. They are not a dosing recommendation.

Published research has used different experimental protocols depending on the compound, formulation, route, indication and study design. These study protocols should not be interpreted as established clinical dosing recommendations.

Important pharmacology

Mechanistic uncertainty

Because no validated receptor has been identified, pharmacodynamic predictions for DSIP are speculative. Mechanistic and animal findings should not be read as demonstrated human effects.

Context dependence

Reported effects in the literature vary with timing, species, and experimental model, which complicates translation to human sleep outcomes.

Side effects

  • Human safety data limited
  • Tolerability not well characterized

Human safety and long-term tolerability are not well characterized. Published studies are small and old, and a reliable adverse-event profile cannot be stated from the available evidence.

Research evidence

Early human sleep studies

Human Clinical Trial (older, small): reported effects on sleep parameters were inconsistent across studies.

Animal sleep and stress models

Animal: preclinical studies suggest modulation of sleep-related and stress-related physiology.

Neuroendocrine investigations

Mechanistic: studies have examined interactions with pituitary and stress-hormone signaling.

Overall evidence position

Review: modern controlled human clinical evidence remains limited and mixed.

Scientific references

  • Delta sleep-inducing peptide (DSIP): a still unresolved riddle

    Kovalzon VM, Strekalova TV · Journal of Neurochemistry · 2006

    Journal of Neurochemistry (PubMed-indexed review)

    ReviewPubMed
  • Isolation of a sleep-inducing peptide from cerebral venous blood

    Schoenenberger GA, Monnier M · PNAS · 1977

    Original isolation work by Monnier and Schoenenberger

    AnimalPubMed
  • DSIP in human sleep: clinical observations

    Neuropsychobiology · 1984

    Older human experimental sleep literature (PubMed-indexed)

    Human Clinical TrialPubMed
  • DSIP and neuroendocrine regulation

    PubMed-indexed mechanistic studies

    MechanisticPubMed
  • DSIP effects on stress responses in animal models

    PubMed-indexed preclinical studies

    AnimalPubMed